To be located near Abidjan, Côte d’Ivoire, the manufacturing facility will be completed in three phases. Credit: Shanghai Fosun Pharmaceutical（Group）Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) is to collaborate with the International Finance Corporation (IFC) to construct a new pharmaceutical production facility and distribution hub near Abidjan, Côte d’Ivoire.

The IFC will provide two loans totalling $53.49m (€50m) to Fosun Pharma’s subsidiaries.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The funding will support the new production plant and distribution hub, which is aimed at enhancing access to high-quality medicines in Africa.

The manufacturing site will be completed in three phases and will produce anti-bacterial medicines and anti-malarial drugs.

Its estimated production capacity on completion is five billion tablets per year.

Fosun Pharma announced that the new facility will improve access to affordable life-saving drugs across west Africa and facilitate the transfer of medical and manufacturing knowledge to the African continent, supporting the long-term growth of the health sector in the region.

Fosun Pharma chairman Wu Yifang stated: “We are glad to be supported by IFC to localise pharmaceutical manufacturing and distribution in Africa.

“Since 2006, IFC has repeatedly provided support to Fosun Pharma, which is committed to ensuring the continuous accessibility and affordability of pharmaceutical products and improving the resilience of healthcare supply chains in the region.”

Data from the World Health Organisation shows that more than 95% of global malaria cases and deaths occur in sub-Saharan Africa.

IFC Africa vice president Sérgio Pimenta said: “Strengthening Africa’s healthcare infrastructure and capabilities is absolutely essential for the continent’s future social and economic development, especially in the wake of Covid-19.

“IFC’s partnership with Fosun will increase Africa’s ability to manufacture essential drugs locally, helping patients more easily access high-quality, affordable medicines.”